Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Looking Into NextGen Healthcare's Return On Capital Employed

According to Benzinga Pro data NextGen Healthcare (NASDAQ:NXGN) posted a 93.3% decrease in earnings from Q3. Sales, however, increased by 1.03% over the previous quarter to $151.26 million.

Benzinga

Lulus Fashion Lounge Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Lulus Fashion Lounge (NASDAQ:LVLU) earned $2.04 million, a 123.28% increase from the preceding quarter. Lulus Fashion Lounge also posted a total of $111.90 million in sales, a 15.64% increase since Q4.

Benzinga

Looking Into Elys Game Technology's Return On Capital Employed

According to data from Benzinga Pro, during Q1, Elys Game Technology's (NASDAQ:ELYS) reported sales totaled $12.24 million. Despite a 68.73% increase in earnings, the company posted a loss of $2.55 million.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Adamis Pharmaceuticals's Return On Capital Employed Overview

Adamis Pharmaceuticals (NASDAQ:ADMP) brought in sales totaling $1.16 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 18.01%, resulting in a loss of $10.35 million.

Benzinga

Scholar Rock Holding Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data, during Q1, Scholar Rock Holding (NASDAQ:SRRK) posted sales of $33.19 million. Earnings were up 77.86%, but Scholar Rock Holding still reported an overall loss of $7.95 million.

Benzinga

OMNIQ's Return On Capital Employed Insights

Benzinga Pro data, OMNIQ (NASDAQ:OMQS) reported Q1 sales of $26.32 million. Earnings fell to a loss of $2.57 million, resulting in a 15.98% decrease from last quarter.

Benzinga

What's Going On With Bed Bath & Beyond Stock Today

Bed Bath & Beyond Inc (NASDAQ: BBBY) shares were initially trading lower Wednesday after several analysts cut price targets on the stock, but have since reversed.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Looking Into Park City Gr's Return On Capital Employed

According to Benzinga Pro, during Q3, Park City Gr (NASDAQ:PCYG) earned $1.09 million, a 24.76% increase from the preceding quarter. Park City Gr also posted a total of $4.56 million in sales, a 4.64% increase since Q2.

Benzinga

Looking Into XpresSpa Group's Return On Capital Employed

Benzinga Pro data, XpresSpa Group (NASDAQ:XSPA) reported Q1 sales of $24.05 million. Earnings fell to a loss of $2.76 million, resulting in a 250.44% decrease from last quarter.

Benzinga

Angion Biomedica's Return On Capital Employed Overview

Benzinga Pro data, Angion Biomedica (NASDAQ:ANGN) reported Q1 sales of $1.65 million. Earnings fell to a loss of $14.24 million, resulting in a 195.63% decrease from last quarter.

Benzinga

INVO Bioscience's Return On Capital Employed Overview

INVO Bioscience (NASDAQ:INVO) brought in sales totaling $162.60 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 2959.58%, resulting in a loss of $2.77 million.

Benzinga

Here's How Much $100 Invested In Nasdaq 10 Years Ago Would Be Worth Today

Nasdaq (NASDAQ:NDAQ) has outperformed the market over the past 10 years by 10.7% on an annualized basis producing an average annual return of 21.71%. Currently, Nasdaq has a market capitalization of $25.13 billion.

Benzinga

Why Neptune Wellness Solutions Shares Are Nosediving Today

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares are trading lower by 32.2% to $1.97 after the company announced a $5 million registered direct offering.

Benzinga

Why Exela Technologies Shares Are Popping Off Today

Exela Technologies Inc (NASDAQ: XELA) shares are trading higher by 27.4% to $0.17 after the company announced a new customer win of $136 million in total contract value.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Worksport Launches Storefronts On Amazon, eBay And Walmart Marketplace

Worksport Ltd (NASDAQ:WKSP) has launched its eCommerce storefronts on Amazon.com (NASDAQ:AMZN), eBay (NASDAQ:EBAY), and Walmart (NYSE:WMT) Marketplace. N.A. Williams Company will execute Worksport’s marketing campaigns on each platform with account executives and marketing managers. The move is expected to drive sales higher and is the result of the company’s restructuring plan. “Our teams and I are thrilled to provide our…

Benzinga

GBS: GBS' Prints Are All Over It

By John Vandermosten, CFA NASDAQ:GBS READ THE FULL GBS RESEARCH REPORT

Benzinga

10 Psychedelics CEOs To Pay Attention To In 2022

By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both private and public.

Benzinga

Expert Ratings for Blink Charging

Blink Charging (NASDAQ:BLNK) has observed the following analyst ratings within the last quarter:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Expert Ratings for Pennant Gr

Within the last quarter, Pennant Gr (NASDAQ:PNTG) has observed the following analyst ratings:

Benzinga

Where Regency Centers Stands With Analysts

Analysts have provided the following ratings for Regency Centers (NASDAQ:REG) within the last quarter:

Benzinga

Analyzing Nasdaq's Short Interest

Nasdaq's (NASDAQ:NDAQ) short percent of float has risen 5.19% since its last report. The company recently reported that it has 1.62 million shares sold short, which is 1.42% of all regular shares that are available for trading.

Benzinga

Expert Ratings for Sonder Holdings

Sonder Holdings (NASDAQ:SOND) has observed the following analyst ratings within the last quarter:

Benzinga

What 9 Analyst Ratings Have To Say About Intuitive Surgical

Within the last quarter, Intuitive Surgical (NASDAQ:ISRG) has observed the following analyst ratings:

Benzinga

Moderna's Bivalent COVID-19 Booster Shows Antibody Response Against Omicron Subvariants

Moderna Inc (NASDAQ:MRNA) has released new clinical data on its bivalent (omicron) COVID booster candidate, mRNA-1273.214. One month after administration in previously vaccinated and boosted participants, a 50 µg booster dose of mRNA-1273.214 elicited potent neutralizing antibody responses against the omicron subvariants BA.4 and BA.5. The company is working on completing regulatory submissions…

Benzinga

Morgan Stanley Sees Further Share Gains For AMD - Read Why

Morgan Stanley analyst Joseph Moore reinstated Advanced Micro Devices, Inc (NASDAQ: AMD) wi

1 … 363 364 365 366

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

313 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.